Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
2s Biochemical Society Transactions ( 1 996) 24 Mechanism of NFKB activation by interleukin-1 and tumour necrosis factor in endothelial cells I +TNF CI + I L I 112 3 4 516 7 8 9 ANDREW BOWIE, PAUL N. MOYNAGH* and LUKE A.J. ONEILL CI Biochemistry Department, Trinity College Dublin, Ireland and *Pharmacology Department, University College Dublin, Ireland. Endothelial cells (ECs) are a key target for the pleiotropic proinflammatory cytokines interleukin-I (ILI) and tumour necrosis factor (TNF). Activation of ECs by these cytokines leads to altered gene expression, although the molecular basis of this process is unclear and remains the subject of much investigation. However, IL1 and TNF potently activate the transcription factor NFKBin many cell types [I], and this is likely to be a key step in the induction of EC genes by these cytokines. Evidence from other cell types (T cell lines in particular) has suggested that the mechanism of activation of NFKBis common to both cytokines and may involve oxidative stress (an increase in intracellular reactive oxygen species (ROS) or hydrogen peroxide) [2, 31. We have tested this oxidative stress model in ECs using human umbilical vein endothelial cells (HUVECs) and a recently described immortalised human EC line, ECV304, which we have previously characterised as a good model for EC activation by ILI and TNF [4]. NFKB activation was assessed by treating confluent cells with various stimulants, and isolating nuclear extracts by the method of Osborn et a1 [5]. Extracts (1 or 2pg protein) were incubated with [32P] labelled DNA containing the NFKB consensus sequence. Protein-bound DNA was separated from unbound DNA by native polyacrylamide gel electrophoresis. The gels were then dried and autoradiographed. Competition analysis with unlabelled wild-type and mutant NFKB prode confirmed that protein-DNA complexes were specific for NFKB.Both ECV304 cells and HUVECs showed a time-dependent activation of NFKBin response to 10 n d m l ILI or TNF or 100 ndml phorbol 12-myristate 13-acetate (PMA) that was detectable from 5-15 min, peaked at 30 min-l h and remained elevated for up to 48 h after stimulation. Pyrrolidine dithiocarbamate (PDTC) has been shown to inhibit NFKBactivation in certain cells, and has been implicated as a general inhibitor of NFKBthat acts independently of the activating agent and cell line used [3]. It has been suggested that PDTC inhibition is mediated through its antioxidant properties, and this has been used as further evidence for the model of activation by oxidative stress [3]. We have previously shown that PDTC inhibits NFKBactivated by TNF and PMA, but not ILI, in ECV304 cells [4]. Here, in HUVECs, NFKB activation by PMA, but not JLI or TNF was inhibited consistently, at PDTC concentrations of 0.01-10 mM. These novel findings indicate that PDTC may not in fact inhibit NFKBindependent of the activating agent. It is conceivable that the PDTC-sensitivity of TNF and PMA in ECV304s and PMA in HUVECs is due to an involvement of ROS or hydrogen peroxide in these pathways, but not those that are insensitive (ILI in ECV304s and ILI and TNF in HUVECs). To test this hypothesis, experiments involving hydrogen peroxide were performed. Since hydrogen peroxide freely diffuses across the cell membrane, measuring extracellular release is an indication of ide release bv IL I -.TNF- and Table 1 PMA- treated ECV304 cells. Hydrogen peroxide release from cells was measured by the horseradish peroxidase-mediated oxidation of the fluorescent probe scopoletin to its non-fluorescent oxidised form [6]. The data is expressed as the mean f S.E.M. for five experiments, each performed in triplicate. There was no significant difference between values for stimulated and control cells, either overall (values below) or in any single experiment. Measured values varied from 0.9 to 14.9 pmoledmidmg protein. Treatment H 2 0 2 release (pmoles/min/mg protein) 6.7 f 1.6 Control 6.6 i 1.4 10 ng/ml IL1 7.6 h 1.7 10 ng/ml TNF 8.2 f 2.3 100 n g h l PMA Abbreviations used: EC. endothelial cell: ILl. interleukin-I : NAC, N-acetyl cysteine; PDTC; p rrolidine dithiocardamate; PMA, phorbol 12-myristate 13-acetate; R&, reactive oxygen species; TNF, tumour necrosis factor +IL1 I + TNF 10 111 12 13 14115 16 17 18 Fig. 1 Effect of hvdroeen Deroxide on NFKB activ u bv sub-0Dtlmd doses of ILI and TNF. ECV304s (lanes 1-9) or HUVECs (lanes 1018) were pretreated for 3 h with 0 (lanes I , 2, 6, 10, 1 I and 15), 0.01 (lanes 3. 7. 12 and 16). 0.1 (lanes 4. 8, 13 and 17) or 1 mM hydrogen peroxide (lanes 51'9, 14'and 18) before stimulation with medium (C, control) or I ng/ml JLI or TNF for 1 h. Nuclear extracts were assessed for the presence of NFKB. Retarded protein-DNA complexes are shown. Representativeof four experiments. intracellular levels. Table 1 shows that there was no significant increase in hvdroeen Deroxide release from ECV304 cells uDon exposure to I i l , T-NF or PMA. This suggests that the sensitiviti of the TNF and PMA pathways to PDTC in ECV304s is not due to an involvement of hydrogen peroxide in these pathways. Treatment of ECV304 cells or HUVECs with 0.01-10 mM hydrogen peroxide alone failed to activate NFKB.In addition, Figure 1 shows that not only was hydrogen peroxide unable to potentiate ILI- or TNFactivated NFKB in either ECV304 cells or HUVECs, but in fact higher doses proved inhibitory . Hydrogen peroxide has been shown to activate NFKBin some cell types [2] but not others [7,8]. Bradley er a1 have also shown it to be ineffective in ECs [9]. The results here suggest that hydrogen peroxide is unlikely to be important in either the PDTC-sensitive or PDTC-insensitive activation of NFKBin ECs. The effect of another antioxidant, N-acetyl cysteine (NAC), on NFKBactivation was also determined in order to ascertain whether a similar pattern of inhibition to PDTC would be observed. NAC is a glutathione precursor and ROS scavenger that is unrelated in structure to PDTC. It has been shown to inhibit NFKBin certain cell types [2, 101. Here, NAC (1-40 mM) had no effect on ILI-, TNF- or PMA-activated NFKB in either ECV304s or HUVECs, although inhibition of TNF-activated NFKB in Jurkat T cells was seen, as reported by Schreck er a1 [4]. Since NAC had no inhibitory effect on any of the NFKBactivating agents in the ECs it is unlikely that ROS are involved in NFKB activation in ECs. Additionally, since NAC did not give a similar pattern of inhibition to PDTC, it is likely that the differential inhibition by PDTC may be independent of its antioxidant properties. The precise target for PDTC remains to be determined. In summary, these results demonstrate that PDTC does not inhibit NFKB independently of the activating agent in endothelial cells. Hydrogen peroxide or ROS are unlikely to be involved in either the PDTC-sensitive or the PDTC-insensitive pathways to NFKB activation in endothelial cells, and hence the oxidative stress model for NFKB activation may not apply to ILI and TNF in endothelial cells. Futhermore, the basis of the differential inhibition by PDTC in endothelial cells may be independent of its antioxidant properties since another antioxidant, NAC, had no inhibitory effect on IL1-, TNF- or PMA-activated NFKB. Work was supported by FORBAIRT and The Irish Heart Foundation. 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. Baeuerle, P.A. (1991) Biochim. Biophys. Acta 1072, 63-80 Schreck, R., Rieber, P.L. and Baeurele, P.A. (1992) EMBO J. 10, 2247-2258 Schreck, R., Meier, B., Mannel, D.N., Droge, W. and Baeuerle, P.A. (1992) J. Exp. Med. 175, 1181-1194 Bowie. A.. Movnaeh. P.N. and O'Neill, L.A.J. (1994) Biochem. Soc.i'rak. 22, 109s Osborn. L.. Kunkel. S. and Nabel. G.J. (1989) . , Proc. Natl. Acad. Sci. 'U.S.A. 86, 2336-2340' Hame. J.D.I. and Nathan. C.F. (1985) . , J. Immunol. Meth. 78,523-326 Brennan, P. and ONeill, L.A.J. (1995) Biochim. Biophys. Acta 1260, 167-175 Menon, S.D., Qin, S., Guy, G.R. and Tan, Y.H. (1993) J. Biol. Chem. 268. 26805-26812 Bradley, J.R., Johnson, D.R. and Pober, J.S. (1993) Am. J. Pathol. 142, 1598-1609 Meyer, M., Schreck, R. and Baeuerle, P.A. (1993) EMBO J. 12. 2005-2015